Benzathine penicillin G
Pregnancy & gynaecology-specific. Every dose row is source-referenced; verify against institutional protocols.
Benzathine penicillin GLong-acting IM penicillin
Regimens checked: 2026-10-17. Each indication has its own preparation, limits and safety checks.
| Indication | Dose | Route | Frequency | Duration / preparation | Maximum | Monitoring / cautions |
|---|---|---|---|---|---|---|
Primary, secondary or early latent syphilis after staging | 2.4 million units | Deep IM ONLY | One initial dose; in pregnancy CDC permits an additional 2.4-million-unit dose one week later | Initial episode; document any indicated extra dose and follow-up · Use a product labelled penicillin G BENZATHINE alone, e.g. the full prefilled Bicillin L-A syringe labelled 2.4 million units (nominal 4 mL presentation); no dilution. Powder products require their own manufacturer reconstitution, and overfill means the prefilled presentation is not a universal units/mL recipe
| 2.4 million units per dose; do not substitute benzathine for neurosyphilis therapy | Monitor
|
Late latent syphilis or unknown duration without neurosyphilis | 2.4 million units | Deep IM ONLY | Every 7 days for 3 doses | Three-weekly-dose course; >9 days between doses in pregnancy requires restarting the full course · Use a product labelled penicillin G BENZATHINE alone, e.g. the full prefilled Bicillin L-A syringe labelled 2.4 million units (nominal 4 mL presentation); no dilution. Powder products require their own manufacturer reconstitution, and overfill means the prefilled presentation is not a universal units/mL recipe
| 7.2 million units total across three correctly timed doses | Monitor
|
Pregnancy safety
Stage-appropriate penicillin treats maternal infection and prevents fetal disease
Lactation
Maternal treatment is used when indicated; assess infant exposure and congenital infection risk